PASITHEA THERAPEUTICS CORP (KTTA) Stock Cash Flow
NASDAQ:KTTA • US70261F2020
Current stock price
0.7 USD
-0.02 (-2.78%)
At close:
0.7 USD
0 (0%)
After Hours:
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -15.51M | -11.73M | -2.17M | -41.00K | |||
| Depreciation Amortization | 648.50K | 5.10K | 1.40K | N/A | |||
| Change In Working Capital | 1.57M | 845.40K | 111.20K | 2.30K | |||
| Other non cash items | -140.30K | -2.81M | -1.11M | N/A | |||
| OPERATING CASH FLOW | -13.43M | -13.69M | -3.17M | -38.70K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -34.30K | -107.10K | -21.50K | N/A | |||
| Other Investing Activity | 433.30K | -2.82M | N/A | N/A | |||
| INVESTING CASH FLOW | 399.00K | -2.93M | -21.50K | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | 0.00 | 0.00 | N/A | N/A | |||
| Stock Issued/Repurchased | -3.73M | -3.21M | 35.37M | 282.30K | |||
| Other Financing Activity | 0.00 | 0.00 | 20.55M | N/A | |||
| FINANCING CASH FLOW | -3.73M | -3.21M | 55.93M | 282.30K | |||
| Exchange Rate Effect | -4.00K | 9.90K | -10.60K | N/A | |||
| CHANGE IN CASH | -16.76M | -19.81M | 52.72M | 243.70K | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -13.43M | -13.69M | -3.17M | -38.70K | |||
| Capital Expenditure | -34.30K | -107.10K | -21.50K | N/A | |||
| FREE CASH FLOW | -13.46M | -13.80M | -3.20M | -38.70K | |||
All data in USD